ClinicalTrials HQ

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Recruiting · NCT07205887 · Registry updated 2026-09-04
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVOEmbolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, eye disorder, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorderRecruitingPhase 22026-09-04NCT07205887

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
EyeBiotech Ltd.5

55 results · Page 1 of 3

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Abilene, TexasAbileneUnited States1
Amarillo, TexasAmarilloUnited States1
Asheville, North CarolinaAshevilleUnited States1
Austin, TexasAustinUnited States1
Austin, TXAustinUnited States3
Bellaire, TexasBellaireUnited States1
Bellaire, TXBellaireUnited States4
Bloomfield, New JerseyBloomfieldUnited States1
Bloomfield, NJBloomfieldUnited States3
Burleson, TexasBurlesonUnited States2
Cary, North CarolinaCaryUnited States2
Dallas, TexasDallasUnited States1
Dallas, TXDallasUnited States3
Florida Retina InstituteJacksonvilleUnited States4
Florida Retina InstituteOrlandoUnited States10
Fort Lauderdale, FLFort LauderdaleUnited States3
Fort Lauderdale, FloridaFort LauderdaleUnited States1
Germantown, TennesseeGermantownUnited States1
Glendale, CAGlendaleUnited States2
Glendale, CaliforniaGlendaleUnited States1
Hagerstown, MarylandHagerstownUnited States1
Hagerstown, MDHagerstownUnited States3
Knoxville, TennesseeKnoxvilleUnited States1
Lemont, ILLemontUnited States3
Lemont, IllinoisLemontUnited States1